NCT04559009View on ClinicalTrials.gov

COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Covid19Amyotrophic Lateral Sclerosis
Trial Locations (1)

28207

Neurosciences Institute, Neurology - Charlotte, Charlotte

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT04559009 - COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry | Biotech Hunter | Biotech Hunter